OmniAb Liabilities And Stockholders Equity from 2010 to 2024
| OABI Stock | USD 3.79 0.21 5.25% |
Liabilities And Stockholders Equity | First Reported 2010-12-31 | Previous Quarter 375.2 M | Current Value 364.9 M | Quarterly Volatility 52 M |
Check OmniAb financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OmniAb's main balance sheet or income statement drivers, such as Net Interest Income of 4.7 M, Depreciation And Amortization of 16.4 M or Interest Expense of 708.8 K, as well as many indicators such as Price To Sales Ratio of 34.39, Dividend Yield of 0.0 or PTB Ratio of 3.58. OmniAb financial statements analysis is a perfect complement when working with OmniAb Valuation or Volatility modules.
OmniAb | Liabilities And Stockholders Equity |
Latest OmniAb's Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of OmniAb Inc over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. OmniAb's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OmniAb's overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
OmniAb Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 292,291,629 | |
| Geometric Mean | 288,544,405 | |
| Coefficient Of Variation | 17.80 | |
| Mean Deviation | 39,962,172 | |
| Median | 262,320,000 | |
| Standard Deviation | 52,037,074 | |
| Sample Variance | 2707.9T | |
| Range | 158.9M | |
| R-Value | 0.75 | |
| Mean Square Error | 1256.8T | |
| R-Squared | 0.57 | |
| Significance | 0 | |
| Slope | 8,777,347 | |
| Total Sum of Squares | 37910T |
OmniAb Liabilities And Stockholders Equity History
About OmniAb Financial Statements
Investors use fundamental indicators, such as OmniAb's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although OmniAb's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 375.2 M | 364.9 M |
Currently Active Assets on Macroaxis
When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:Check out the analysis of OmniAb Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.